Document:

Exhibit 10.1 

PATENT PURCHASE AGREEMENT

               This Patent Purchase Agreement (hereinafter referred to as "Agreement") is made effective March 24, 2008 (the "Effective Date"), by and between Phillips Capital (the "HOLDER") and Aquamer Medical Corp. (the "ASSIGNEE").

               Recitals

               WHEREAS, Michael Magliochetti (the "INVENTOR") is the inventor of the following Intellectual Property, entitled Hydropatella Implant, being all of the rights, title and interest in and to the pending US Patent, identified as Attorney Docket No. 105554-2 which application was filed in the United States Patent and Trademark Office on September 30, 2005, as Application No, 60/722,277 (the "PATENT"), and

               WHEREAS, the INVENTOR transferred all rights, title and interest in the PATENT (the "Patent") to the HOLDER on January 10, 2006, and;

               WHEREAS the HOLDER is desirous of transferring ownership (assigning) of the PATENT to the ASSIGNEE and the ASSIGNEE is desirous of accepting ownership (assignment) of the PATENT in exchange for the issuance by the ASSIGNEE of 10,000,000 shares of the ASSIGNEE's common stock.

               NOW THEREFORE, in consideration of the term and covenants contained herein, the PARTIES hereto agree as follows:

               ARTICLE 1:  ASSIGNMENT

               The HOLDER hereby grants to ASSIGNEE an Assignment of the PATENT. HOLDER agrees to record transfer of ownership of the PATENT at the United States Patent and Trademark Office by assignment to ASSIGNEE in a timely manner.

               ARTICLE 2:  CONSIDERATION

               In consideration of the assignment of the PATENT to ASSIGNEE, ASSIGNEE shall pay to the designees of the HOLDER 10,000,000 shares of ASSIGNEE's common stock. The parties understand that shares issued by ASSIGNEE in connection with the transaction contemplated herein shall be restricted in accordance with Rule 144 of the Securities Act as promulgated under the rules of the United States Securities and Exchange Commission.

               ARTICLE 3:  WARRANTIES AND REPRESENTATIONS OF THE HOLDER

               HOLDER represents and warrants that:

               1. It is legally entitled to enter into this transaction

               2. The pending patent is free and clear of any liabilities, except for certain legal fees, which will be paid by Holder before March 31, 2008

               3. No assignments or licenses are outstanding, EXCEPT for those of HOLDER, which will terminate upon signature of the Agreement

               ARTICLE 4:  WARRANTIES AND REPRESENTATIONS OF THE ASSIGNEE

               ASSIGNEE represents and warrants that:

               1. The shares issued by it to the designees of the HOLDER have been duly authorized and, when issued, the designees of the Holder will acquire good and valid title to the shares free and clear of any liabilities

               IN WITNESS WHEREOF, the parties have executed this Agreement on March 24, 2008.

Phillips Capital, a corporation.

  By:/s/Laura Magliochetti___

  Laura Magliochetti

  Its: President

Aquamer Medical Corp.

  By:_/s/Marshall   Sterman__

  Marshall Sterman

  Its: PresidentExhibit 4.1

 Exhibit 4.1 
 FIRST SUPPLEMENTAL FOUNDER WARRANT PURCHASE AGREEMENT 
 This First Supplemental Founder
Warrant Purchase Agreement (this “Agreement”), dated March 18, 2008, is to the Founder Warrant Purchase Agreement, dated as of May 11, 2006 (the “Founder Warrant Purchase Agreement”), by and
between MARATHON ACQUISITION CORP., a Delaware corporation, (the “Company”), and MARATHON INVESTORS, LLC, a Delaware limited liability company (the “Purchaser”). 
 WHEREAS, each of the Company and the Purchaser desire to amend the Founder Warrant Purchase Agreement in the manner set forth herein; 

NOW, THEREFORE, in consideration of the mutual agreements contained herein, and of other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows: 
 1. Founder Warrant Purchase Agreement. The Founder Warrant Purchase Agreement is amended hereby by amending and restating Exhibit B thereto as follows: 
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE PROVISIONS OF ANY
APPLICABLE STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT AND LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED. 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN AGREEMENT BY THE REGISTERED HOLDER
HEREOF NOT TO SELL SUCH SECURITIES UNTIL CONSUMMATION OF A BUSINESS COMBINATION BY THE COMPANY.” 
 2. Miscellaneous.

 a. GOVERNING LAW. THIS AGREEMENT, THE LEGAL RELATIONS BETWEEN AND AMONG THE PARTIES HERETO, THE ADJUDICATION
AND THE ENFORCEMENT HEREOF SHALL BE GOVERNED BY AND INTERPRETED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS FORMED AND TO BE PERFORMED ENTIRELY WITHIN THE STATE OF NEW YORK, WITHOUT REGARD TO THE
CONFLICTS OF LAW PROVISIONS THEREOF TO THE EXTENT SUCH PRINCIPLES OR RULES WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION. 
 b. Severability. If any provision in this Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions, or of such
provisions in any other jurisdiction, shall not in any way be affected or impaired thereby. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith
to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated to the greatest extent possible.

 c. Counterparts. This Agreement may be executed in any number of counterparts, each of which so executed shall
be deemed to be an original; but such counterparts shall together constitute but one and the same document. 
 [Remainder of Page
Intentionally Left Blank] 

 IN WITNESS WHEREOF, the parties hereto have executed this First Supplemental Founder Warrant Purchase
Agreement as of the date first written above. 
  

			
	 MARATHON ACQUISITION CORP.

		
	By:	 	 /s/ Michael S. Gross

	Name:	 	Michael S. Gross
	Title:	 	Chairman, Chief Executive Officer and Secretary
	
	MARATHON INVESTORS, LLC
		
	By:	 	 /s/ Michael S. Gross

	Name:	 	Michael S. Gross
	Title:	 	Managing MemberExhibit 4.2

 Exhibit 4.2 
 FIRST SUPPLEMENTAL WARRANT AGREEMENT 
 This First Supplemental Warrant Agreement (this
“Agreement”), dated March 18 , 2008, is to the Warrant Agreement, dated as of August 30, 2006 (the “Warrant Agreement”), by and between MARATHON ACQUISITION CORP., a Delaware corporation,
(the “Company”), and THE BANK OF NEW YORK, a New York trust company (the successor thereto under the Warrant Agreement, MELLON INVESTOR SERVICES LLC, a New Jersey limited liability company, the “Warrant
Agent”). 
 WHEREAS, Section 6.01(a)(i) of the Warrant Agreement provides that such Warrant Agreement may be amended
by the parties thereto, without the consent of the Holder (as defined therein) of any Warrant (as defined therein), for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained therein, or making
any other provisions with respect to matters or questions arising under the Warrant Agreement that is not inconsistent with the provisions of the Warrant Agreement or the Warrant Certificates (as defined therein); and 
 WHEREAS, as contemplated by the Warrant Agreement, in connection with the Company’s IPO (as defined in the Warrant Agreement) the Company
issued an aggregate of 40,035,850 Units (as defined in the Warrant Agreement), including an aggregate of 40,035,850 IPO Warrants (as defined in the Warrant Agreement) underlying such Units, and an aggregate of 5,500,000 Sponsor Warrants (as defined
in the Warrant Agreement), and as a result thereof, has an aggregate of 45,535,850 outstanding Warrants; and  
 NOW,
THEREFORE, in consideration of the mutual agreements contained herein, and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree
as follows: 
 1. Warrant Agreement.
 a. Pursuant to Section 6.01(a)(i) thereto, the Warrant Agreement is amended hereby by amending and restating Section 1.02(a) thereto as follows: 
 “One or more Warrant Certificates evidencing Warrants to purchase not more than 45,535,850 Shares (subject to adjustment as provided for in
Section 2.04) may be executed by the Company and delivered to the Warrant Agent upon the execution of this Agreement or from time to time thereafter.” 
 2. Miscellaneous. 
 a. GOVERNING LAW. THIS AGREEMENT, THE LEGAL
RELATIONS BETWEEN AND AMONG THE PARTIES HERETO, THE ADJUDICATION AND THE ENFORCEMENT HEREOF SHALL BE GOVERNED BY AND INTERPRETED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS FORMED AND TO BE PERFORMED
ENTIRELY WITHIN THE STATE OF NEW YORK, WITHOUT REGARD TO THE CONFLICTS OF LAW PROVISIONS THEREOF TO THE EXTENT SUCH PRINCIPLES OR RULES WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION. 
 b. Jurisdiction; Waiver of Jury Trial. Except as otherwise expressly provided in this Agreement, each of the parties hereto
irrevocably and unconditionally submits to the exclusive jurisdiction of the United States District Court for the Southern District of New York or, if such court does not have jurisdiction, the New York State Supreme Court in the Borough of
Manhattan, in any legal action arising out of or relating to this Agreement, agrees that all claims in respect of the legal action may be heard and determined in any such court and agrees not to bring any legal action arising out of or relating to
this Agreement in any other court. Each of the parties hereto irrevocably waives any and all right to trial by jury in any legal proceeding arising out of or related to this Agreement or the transactions contemplated hereby. 

 c. Benefits of Agreement. Nothing in this Agreement expressed or implied and
nothing that may be inferred from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the Company, the Warrant Agent and their respective successors and assigns, the
Beneficial Owners (as defined in the Warrant Agreement) and the Holders any right, remedy or claim under or by reason of this Agreement or of any agreement hereof; and all agreements contained in this Agreement shall be for the sole and exclusive
benefit of the Company and the Warrant Agent and their respective successors and assigns and of the Beneficial Owners and Holders. 
 d. Indemnity. The Company agrees to pay the Warrant Agent compensation to be agreed upon by the Warrant Agent and the Company for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for all reasonable
out-of-pocket expenses (including reasonable counsel fees) incurred by the Warrant Agent in connection with the services rendered by it under the Warrant Agreement and this Agreement. The Company also agrees to indemnify the Warrant Agent for, and
hold it harmless against, any loss, liability or expense incurred without (or other than as the result of) negligence or willful misconduct on the part of the Warrant Agent (each as determined by a final non-appealable order of a court of competent
jurisdiction), arising out of or in connection with its acting as Warrant Agent under the Warrant Agreement and this Agreement. The execution of this Agreement by the Warrant Agent shall in no case be deemed to constitute negligence or willful
misconduct on the part of the Warrant Agent. 
 e. Liability. The Company agrees that Section 5.02(l) of
the Warrant Agreement is incorporated herein by reference. 
 f. Severability. If any provision in this
Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions, or of such provisions in any other jurisdiction, shall not in any way be affected or impaired thereby.
Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as
possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated to the greatest extent possible. 
 g. Counterparts. This Agreement may be executed in any number of counterparts, each of which so executed shall be deemed to be
an original; but such counterparts shall together constitute but one and the same document. 
 [Remainder of Page Intentionally Left
Blank] 

 IN WITNESS WHEREOF, the parties hereto have executed this First Supplemental Warrant Agreement as of the
date first written above. 
  

			
	MARATHON ACQUISITION CORP.
		
	By:	 	 /s/ Michael S. Gross

	Name:	 	Michael S. Gross
	Title:	 	Chairman, Chief Executive Officer and Secretary
	
	MELLON INVESTOR SERVICES LLC
		
	By:	 	 /s/ Christopher T. Coleman

	Name:	 	Christopher T. Coleman
	Title:	 	Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}]]